Cancer Research Technology
Log in Register
Menu

BG-1 Cell Line

Invented by Michael E. Berens, Ph.D.

Info

Catalogue Number 153873
Antigen/Gene or Protein Targets Ovarian cancer
Parental Line primary ovarian carcinoma
Host Human
Tissue Ovary
Disease Keywords Ovarian carcinoma
Model Cancer Model
Relevance BG-1 is a human ovarian carcinoma cell line that has functional and clinically relevent estrogen receptors and progesterone receptors.
Research Area Cancer

References

There are 6 reference entries for this reagent.

View All References

References: 6 entries

Baldwin et al. 1998. In Vitro Cell Dev Biol Anim. 34(8):649-54. PMID: 9769151.

BG-1 ovarian cell line: an alternative model for examining estrogen-dependent growth in vitro.

Europe PMC ID: 9769151

Pavlik et al. 1991. Gynecol Oncol. 42(3):245-9. PMID: 1955187.

The growth response of BG-1 ovarian carcinoma cells to estradiol, 4OH-tamoxifen, and tamoxifen: evidence for intrinsic antiestrogen activation.

Europe PMC ID: 1955187

Geisinger et al. 1989. Cancer. 63(2):280-8. PMID: 2910432.

Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors.

Europe PMC ID: 2910432


Add a reference

References: 6 entries

Baldwin et al. 1998. In Vitro Cell Dev Biol Anim. 34(8):649-54. PMID: 9769151.

BG-1 ovarian cell line: an alternative model for examining estrogen-dependent growth in vitro.

Pavlik et al. 1991. Gynecol Oncol. 42(3):245-9. PMID: 1955187.

The growth response of BG-1 ovarian carcinoma cells to estradiol, 4OH-tamoxifen, and tamoxifen: evidence for intrinsic antiestrogen activation.

Geisinger et al. 1989. Cancer. 63(2):280-8. PMID: 2910432.

Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors.


Add a reference

Inventor Information

Inventors

Michael E. Berens, Ph.D.

Michael E. Berens, Ph.D.

Add an inventor